-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EN9PC1RBjUijne+MaHTIWFD5Q5PjhgzlnikkoI7X0wuZhh/9I+D8CceudcZgXTr/ /oA6z62nKiNMBDX4uqejzw== 0000950159-05-000972.txt : 20050818 0000950159-05-000972.hdr.sgml : 20050818 20050818145659 ACCESSION NUMBER: 0000950159-05-000972 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050630 FILED AS OF DATE: 20050818 DATE AS OF CHANGE: 20050818 EFFECTIVENESS DATE: 20050818 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERCEPTIVE ADVISORS LLC CENTRAL INDEX KEY: 0001224962 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: 1934 Act SEC FILE NUMBER: 028-10438 FILM NUMBER: 051035755 BUSINESS ADDRESS: STREET 1: PERCEPTIVE CAPITAL STREET 2: 5437 CONNECTICUT AVENUE NW STE 100 CITY: WASHINGTON STATE: DC ZIP: 20015 BUSINESS PHONE: 2025370029 13F-HR/A 1 perceptive13f.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2005 Check here if Amendment [X]; Amendment Number: 1 ------------ This Amendment (Check only one.): [X] is a restatement. [ ]adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Perceptive Advisors LLC Address: 7284 West Palmetto Park Road, Suite 301 Boca Raton, FL 33433 Form 13F File Number: 28-10438 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Persons Signing this Report on Behalf of Reporting Manager: Name: Joseph Edelman Title: Managing Member Phone: 561-391-7770 Signature, Place, and Date of Signing: /s/ Joseph Edelman New York, NY August 18, 2005 - ------------------ ------------ --------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager is reported in this report and a portion is reported by other reporting manager(s).)
Fair Title Market Shares/ Of Value Prn SH/ Put/ OTHER INVESTMENT VOTING NAME OF ISSUER Class Cusip (x1000) Amount PRN Call MANAGERS DISCRETION AUTHORITY - -------------- -------------- --------- ----------- ---------- ------ -------- ---------- ----------- ----------- ABGENIX INC COM 00339B107 1,492 162000 SH N/A SOLE SOLE AEROGEN INC COM NEW 7779309 7 15148 SH N/A SOLE SOLE AMGEN INC COM 31162100 32,260 482000 SH N/A SOLE SOLE ANDRX CORP DEL ANDRX GROUP 34553107 3,854 189000 SH N/A SOLE SOLE ANTIGENICS INC DEL COM 0370329U5 243 45000 P N/A SOLE SOLE ARENA PHARMACEUTICALS INC COM 40047102 1,211 171300 SH N/A SOLE SOLE ARIAD PHARMACEUTICALS INC COM 04033A100 5,631 853200 SH N/A SOLE SOLE ARRAY BIOPHARMA INC COM 04269X105 5,353 812287 SH N/A SOLE SOLE AVANIR PHARMACEUTICALS CL A 05348P104 2,326 788601 SH N/A SOLE SOLE AVANIR PHARMACEUTICALS CL A 05348P104 1,787 605700 SH N/A SOLE SOLE BIOENVISION INC COM 09059N100 4,191 547167 SH N/A SOLE SOLE BIOGEN IDEC INC COM 09062X103 626 18000 SH N/A SOLE SOLE BIOGEN IDEC INC COM 09062X103 6,257 180000 SH N/A SOLE SOLE BIOGEN IDEC INC COM 09062X103 3,299 94900 SH N/A SOLE SOLE BIOMARIN PHARMACEUTICAL INC COM 09061G101 134 18000 SH N/A SOLE SOLE CAMBRIDGE ANTIBODY TECH GP SPONSORED ADR 132148107 2,411 207891 SH N/A SOLE SOLE CARDIOME PHARMA CORP COM NEW 14159U202 512 85500 SH N/A SOLE SOLE CELGENE CORP COM 1510209S5 1,835 45000 P N/A SOLE SOLE CELGENE CORP COM 151020104 5,015 123000 SH N/A SOLE SOLE CEPHALON INC COM 1567089T8 717 18000 P N/A SOLE SOLE CEPHALON INC COM 1567089T8 1,075 27000 P N/A SOLE SOLE CHARTERMAC SH BEN INT 160908109 8,728 389800 SH N/A SOLE SOLE COLLAGENEX PHARMACEUTICALS I COM 19419B100 654 90250 SH N/A SOLE SOLE CONNETICS CORP COM 2081929G1 594 45000 C N/A SOLE SOLE CORCEPT THERAPEUTICS INC COM 218352102 119 20870 SH N/A SOLE SOLE CUBIST PHARMACEUTICALS INC COM 229678107 420 31500 SH N/A SOLE SOLE CYBERONICS INC COM 23251P9S3 391 9000 P N/A SOLE SOLE CYBERONICS INC COM 23251P9S3 391 9000 P N/A SOLE SOLE CYBERONICS INC COM 23251P102 577 13500 SH N/A SOLE SOLE CYBERONICS INC COM 23251P9S3 5,354 123400 P N/A SOLE SOLE CYBERONICS INC COM 23251P9S3 1,055 243000 P N/A SOLE SOLE CYBERONICS INC COM 23251P9S3 1,953 45000 P N/A SOLE SOLE CYBERONICS INC COM 23251P9S3 3,905 90000 P N/A SOLE SOLE CYBERONICS INC COM 23251P9S3 3,905 90000 P N/A SOLE SOLE CYBERONICS INC COM 23251P102 45,626 1067029 SH N/A SOLE SOLE CYBERONICS INC COM 23251P9S3 2,343 54000 P N/A SOLE SOLE CYBERONICS INC COM 23251P9S3 781 18000 P N/A SOLE SOLE CYBERONICS INC COM 23251P9S3 2,170 50000 P N/A SOLE SOLE CYBERONICS INC COM 23251P102 5,248 122720 SH N/A SOLE SOLE CYBERONICS INC COM 23251P9S3 1,302 30000 P N/A SOLE SOLE CYBERONICS INC COM 23251P9S3 434 10000 P N/A SOLE SOLE CYBERONICS INC COM 23251P102 1,710 40000 SH N/A SOLE SOLE CYPRESS BIOSCIENCES INC COM PAR $.02 2326749U7 5,395 408700 P N/A SOLE SOLE CYPRESS BIOSCIENCES INC COM PAR $.02 2326749I4 601 45500 C N/A SOLE SOLE CYPRESS BIOSCIENCES INC COM PAR $.02 2326749I4 428 33300 C N/A SOLE SOLE DEPOMED INC COM 249908104 403 90000 SH N/A SOLE SOLE DOV PHARMACEUTICAL INC COM 259858108 3,109 161650 SH N/A SOLE SOLE EMISPHERE TECHNOLOGIES INC COM 291345106 417 105506 SH N/A SOLE SOLE ENDO PHARMACEUTICALS HLDGS I COM 29264F205 231 9000 SH N/A SOLE SOLE ENZON PHARMACEUTICALS INC NOTE 4.500% 7/293904AB4 8 33210000 PRN N/A SOLE SOLE EYETECH PHARMACEUTICALS INC COM 3022979U2 569 45000 P N/A SOLE SOLE FIRST HORIZON PHARMACEUTICAL COM 32051K106 9,554 453000 SH N/A SOLE SOLE FISHER SCIENTIFIC INTL INC COM NEW 338032204 1,157 18000 SH N/A SOLE SOLE FLAMEL TECHNOLOGIES SA SPONSORED ADR 338488109 5,170 272102 SH N/A SOLE SOLE GENENTECH INC COM NEW 368710406 31,420 378600 SH N/A SOLE SOLE GENITOPE CORP COM 37229P9H6 578 45000 C N/A SOLE SOLE GENITOPE CORP COM 37229P9H6 578 45000 C N/A SOLE SOLE GENITOPE CORP COM 37229P9I4 3,582 279000 C N/A SOLE SOLE GENITOPE CORP COM 37229P9I4 7,511 585000 C N/A SOLE SOLE GENZYME CORP COM 372917104 33,839 566345 SH N/A SOLE SOLE GILEAD SCIENCES INC COM 375558103 3,686 81020 SH N/A SOLE SOLE HUMAN GENOME SCIENCES INC COM 444903108 548 45000 SH N/A SOLE SOLE IMCLONE SYS INC COM 45245W109 287 9000 SH N/A SOLE SOLE IMCLONE SYS INC COM 45245W109 5,013 157000 SH N/A SOLE SOLE IMCLONE SYS INC COM 45245W109 1,868 58500 SH N/A SOLE SOLE IMMUNICON CORP DEL COM 45260A107 918 182926 SH N/A SOLE SOLE INTERMUNE INC COM 45884X103 870 63000 SH N/A SOLE SOLE INTERMUNE INC COM 45884X103 138 10000 SH N/A SOLE SOLE ISOLAGEN INC COM 46488N103 6,143 1452186 SH N/A SOLE SOLE IVAX CORP COM 465823102 375 18000 SH N/A SOLE SOLE IVAX CORP COM 465823102 1,686 81000 SH N/A SOLE SOLE IVAX CORP COM 465823102 281 13500 SH N/A SOLE SOLE JOHNSON & JOHNSON COM 478160104 3,682 57600 SH N/A SOLE SOLE LIGAND PHARMACEUTICALS INC CL B 53220K207 800 112500 SH N/A SOLE SOLE MEDICIS PHARMACEUTICAL CORP CL A NEW 584690309 8,470 270000 SH N/A SOLE SOLE MEDTRONIC INC COM 585055106 15,376 297000 SH N/A SOLE SOLE MGI PHARMA INC COM 552880106 11,105 486000 SH N/A SOLE SOLE MILLENNIUM PHARMACEUTICALS I COM 599902103 4,010 423000 SH N/A SOLE SOLE NEKTAR THERAPEUTICS COM 640268108 3,388 188448 SH N/A SOLE SOLE NEOPHARM INC COM 6409199G3 270 27000 C N/A SOLE SOLE NEUROCHEM INC COM 64125K101 1,492 140500 SH N/A SOLE SOLE NITROMED INC COM 654798503 382 16400 SH N/A SOLE SOLE NITROMED INC COM 6547989S8 350 18000 P N/A SOLE SOLE NITROMED INC COM 654798503 419 18000 SH N/A SOLE SOLE NITROMED INC COM 654798503 466 20000 SH N/A SOLE SOLE NOVEN PHARMACEUTICALS INC COM 670009109 4,228 240500 SH N/A SOLE SOLE OCCULOGIX INC COM 67461T107 906 108100 SH N/A SOLE SOLE PENWEST PHARMACEUTICALS CO COM 709754105 1,305 108950 SH N/A SOLE SOLE PHARMACOPEIA DRUG DISCVRY IN COM 7171EP101 511 130500 SH N/A SOLE SOLE PROGENICS PHARMACEUTICALS IN COM 743187106 67 3060 SH N/A SOLE SOLE PROGENICS PHARMACEUTICALS IN COM 743187106 33,861 1546864 SH N/A SOLE SOLE PROGENICS PHARMACEUTICALS IN COM 743187106 755 34500 SH N/A SOLE SOLE PROTEIN DESIGN LABS INC COM 74369L103 7,234 351000 SH N/A SOLE SOLE SCHERING PLOUGH CORP PFD CONV MAND 806605606 901 18000 SH N/A SOLE SOLE SEPRACOR INC COM 817315104 7,244 126000 SH N/A SOLE SOLE SERONO S A SPONSORED ADR 81752M101 1,596 99000 SH N/A SOLE SOLE SIERRA HEALTH SVCS INC COM 826322109 1,064 14400 SH N/A SOLE SOLE SIERRA HEALTH SVCS INC COM 826322109 6,459 87400 SH N/A SOLE SOLE SUPERGEN INC COM 868059106 274 51750 SH N/A SOLE SOLE SUPERGEN INC COM 8680599G3 323 65300 C N/A SOLE SOLE SUPERGEN INC COM 868059106 5,087 959800 SH N/A SOLE SOLE SUPERGEN INC COM 8680599H1 178 36000 C N/A SOLE SOLE SUPERGEN INC COM 8680599J7 178 36000 C N/A SOLE SOLE SUPERGEN INC COM 868059106 859 162000 SH N/A SOLE SOLE TARO PHARMACEUTICAL INDS LTD ORD M8737E108 491 18000 SH N/A SOLE SOLE TEVA PHARMACEUTICAL INDS LTD ADR 881624209 4,419 146700 SH N/A SOLE SOLE TRIAD HOSPITALS INC COM 89579K109 8,424 153000 SH N/A SOLE SOLE VERTEX PHARMACEUTICALS INC COM 92532F100 6,181 367270 SH N/A SOLE SOLE VI TECHNOLOGIES INC COM NEW 917920209 2,431 482258 SH N/A SOLE SOLE VICURON PHARMACEUTICALS INC COM 926471103 11,060 396000 SH N/A SOLE SOLE VICURON PHARMACEUTICALS INC COM 926471103 1,951 69850 SH N/A SOLE SOLE VIROPHARMA INC NOTE 6.000% 3/928241AC2 9 17495000 PRN N/A SOLE SOLE WELLPOINT INC COM 94973V107 43,414 621000 SH N/A SOLE SOLE ZONAGEN INC COM 98975L108 2,693 720000 SH N/A SOLE SOLE
FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 114 Form 13F Information Table Value Total: $498,563 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state "NONE" and omit the column headings and list entries.] NONE -----END PRIVACY-ENHANCED MESSAGE-----